Vaxcyte Inc reports results for the quarter ended in March - Earnings Summary

Vaxcyte

08/05/2023 23:03

* Vaxcyte Inc  PCVX.OQ  reported a quarterly adjusted loss
of 70
cents​​ per share for the quarter ended in March. The mean
expectation of seven analysts for the quarter was for a loss
of 83 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Vaxcyte Inc's reported EPS for the quarter was a loss
of 70
cents​.
    * The mean earnings estimate of analysts had fallen by
about 8.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Vaxcyte Inc shares had risen by 37.1% this quarter and
gained 7.2% so far this year.
    * The company reported a quarterly loss of $60.46 million.
    * Wall Street's median 12-month price target for Vaxcyte Inc
is
$68.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
8 at 10:03 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.83          -0.70          Beat
 Dec. 31 2022      -0.93          -1.02          Missed
 Sep. 30 2022      -0.84          -0.93          Missed
 Jun. 30 2022      -0.69          -0.80          Missed